Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania.
diagnostic and predictive genetic analyses
genetic counseling
hereditary breast and ovarian cancer
risk-adapted prevention
rural area
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
13 Oct 2022
13 Oct 2022
Historique:
received:
25
08
2022
revised:
05
10
2022
accepted:
10
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
The German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC) consists of 23 academic centers striving to provide high-quality regional care for affected individuals and healthy at-risk family members. According to the standard operating procedures defined by the GC-HBOC, a Familial Breast and Ovarian Cancer Center was implemented at the University Medicine Greifswald over a four-year period from 2018 to 2021, despite the COVID-19 pandemic. Genetic analyses were performed in a total of 658 individuals, including 41 males, which paved the way to local annual risk-adapted breast cancer surveillance for 91 women and prophylactic surgery for 34 women in 2021. Our experience in the North Eastern part of Germany demonstrates that it is possible to establish a high-risk breast and ovarian cancer service even in a sparsely populated region. Major facilitators are the interdisciplinary collaboration of dedicated local experts, the support of the GC-HBOC, fruitful clinical and scientific cooperations and the use of technical improvements. As a blueprint, our project report may help to further expand the network of specialized and knowledge-generating care for HBOC families.
Identifiants
pubmed: 36292468
pii: healthcare10102021
doi: 10.3390/healthcare10102021
pmc: PMC9601587
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancer Med. 2018 Apr;7(4):1349-1358
pubmed: 29522266
Breast Cancer Res. 2018 Jan 24;20(1):7
pubmed: 29368626
Genet Med. 2019 Aug;21(8):1708-1718
pubmed: 30643217
Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):469-473
pubmed: 33335023
Breast Care (Basel). 2021 Jun;16(3):196-201
pubmed: 34248460
J Telemed Telecare. 2021 Nov 15;:1357633X211052220
pubmed: 34779303
Front Oncol. 2021 Apr 20;11:663419
pubmed: 33959510
Healthcare (Basel). 2021 Apr 01;9(4):
pubmed: 33916104
Gastroenterology. 2000 Dec;119(6):1447-53
pubmed: 11113065
Healthcare (Basel). 2021 Dec 24;10(1):
pubmed: 35052197
Geburtshilfe Frauenheilkd. 2020 Sep;80(9):932-940
pubmed: 32905297
Dig Liver Dis. 2013 Jul;45(7):606-11
pubmed: 23415580
J Genet Couns. 2021 Oct;30(5):1361-1378
pubmed: 34355839
N Engl J Med. 2021 Feb 4;384(5):428-439
pubmed: 33471991
J Med Genet. 2022 Jul;59(7):632-643
pubmed: 34844974
Breast Care (Basel). 2022 Apr;17(2):199-207
pubmed: 35702495
Radiologe. 2021 Feb;61(2):150-158
pubmed: 33433649
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Breast J. 2019 May;25(3):455-460
pubmed: 30953388
Breast Cancer Res. 2019 Apr 29;21(1):55
pubmed: 31036035
Gesundheitswesen. 2021 Nov;83(S 01):S12-S17
pubmed: 34731888
Dtsch Arztebl Int. 2011 May;108(19):323-30
pubmed: 21637635
Cancers (Basel). 2022 Jul 05;14(13):
pubmed: 35805063
Hum Mutat. 2010 May;31(5):588-93
pubmed: 20205264
Breast Cancer Res Treat. 2019 May;175(1):217-228
pubmed: 30725383
Geburtshilfe Frauenheilkd. 2020 Apr;80(4):410-429
pubmed: 32322110
PLoS One. 2017 Oct 20;12(10):e0186043
pubmed: 29053726
Cancers (Basel). 2021 Oct 13;13(20):
pubmed: 34680270
BMC Cancer. 2018 Mar 7;18(1):265
pubmed: 29514593
J Med Genet. 2016 Jul;53(7):465-71
pubmed: 26928436